Prescriptions cannot be written for a diagnosis of type 2 diabetes if a patient does not have a confirmed diagnosis of type 2 diabetes
Some patients take them long-term for maintenance, while others taper off under medical guidance after achieving goals
Lesser Highlights CTs Generic GLP-1 Legislation at National Conference Today, State Senator Matt Lesser , Senate Chair of the Human Services Committee, spoke at the National Academy for State Health Policy (NASHP) Annual Health Policy Conference in San Diego on Connecticuts recently enacted bipartisan prescription drug law, which puts Connecticut in the front of the pack of states in controlling drug costs
In other words, every remaining calorie has to work harder
In addition to its effects on metabolic regulation, GLP-1, when synthesized within the brain, exhibits neuroprotective properties